Format

Send to

Choose Destination
Aging (Albany NY). 2019 Nov 6. doi: 10.18632/aging.102443. [Epub ahead of print]

CCL21 and prognosis in acute coronary syndrome.

Ueland T1,2,3, Aukrust P1,4,2, Caidahl K5,6,7.

Author information

1
Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
2
Faculty of Medicine, University of Oslo, Oslo, Norway.
3
K.G. Jebsen-Thrombosis Research and Expertise Center (TREC), University of Tromsø, Tromsø, Norway.
4
Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.
5
Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
6
Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
7
Departments of Molecular Medicine and Surgery and Clinical Physiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

KEYWORDS:

CCL21; acute coronary syndrome; non-ST-segment elevation myocardial infarction (or NSTEMI); prognosis

PMID:
31694981
DOI:
10.18632/aging.102443
Free full text

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for Norwegian BIBSYS system
Loading ...
Support Center